SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1602)11/5/1998 3:58:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Eagles 1977.

I could understand this happening to a company with only $200,000 in cash. But Cistron has a $13 million war chest which should be protecting shareholder assets. A buyback would and would have rid the manipulation from Cistron's stock long ago.

Not doing one allows Cistron to trade at these pathetic levels...

Why?




To: Dr. John M. de Castro who wrote (1602)11/5/1998 11:31:00 PM
From: Walter Morton  Respond to of 2742
 
You are controlling your temper very well. I think this will explain it: I think, stock prices are based on earnings per share and CIST does not have any.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News